Effects of immunization and checkpoint inhibition on amodiaquine-induced liver injury
If idiosyncratic drug-induced liver injury (IDILI) is immune-mediated, it is possible that an individual’s prior exposure to antigens may affect their susceptibility to IDILI. An individual’s repertoire of memory immune cells is shaped by every past exposure to antigens. Subsequent drug-induced adve...
Main Authors: | Alastair Mak, Alexander Johnston, Jack Uetrecht |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-01-01
|
Series: | Journal of Immunotoxicology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/1547691X.2017.1290716 |
Similar Items
-
Use of an animal model to test whether non-alcoholic fatty liver disease increases the risk of idiosyncratic drug-induced liver injury
by: Alastair Mak, et al.
Published: (2018-01-01) -
Involvement of CCL2/CCR2 macrophage recruitment in amodiaquine-induced liver injury
by: Alastair Mak, et al.
Published: (2019-01-01) -
Exploiting the predictive power of educated spheroids to detect immune-mediated idiosyncratic drug-induced liver injury: the case of troglitazone
by: Salomé Roux, et al.
Published: (2024-04-01) -
Drug-induced liver injury due to varenicline: a case report
by: Sprague David, et al.
Published: (2012-06-01) -
Amodiaquine hydrochloride tablets
by: 982 SIRIM